Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun:273:145-152.
doi: 10.1016/j.atherosclerosis.2018.03.035. Epub 2018 Mar 22.

Serum magnesium, phosphorus, and calcium levels and subclinical calcific aortic valve disease: A population-based study

Takashi Hisamatsu  1 , Katsuyuki Miura  2 , Akira Fujiyoshi  3 , Aya Kadota  2 , Naoko Miyagawa  3 , Atsushi Satoh  4 , Maryam Zaid  5 , Takashi Yamamoto  6 , Minoru Horie  6 , Hirotsugu Ueshima  2 ; SESSA Research Group
Affiliations

Serum magnesium, phosphorus, and calcium levels and subclinical calcific aortic valve disease: A population-based study

Takashi Hisamatsu et al. Atherosclerosis. 2018 Jun.

Abstract

Background and aims: Calcific aortic valve disease (CAVD) is the most common valve disease. Although micronutrients are known to contribute to cardiovascular disease, the relationship with CAVD remains poorly evaluated. We examined the association of serum levels of magnesium, phosphorus, and calcium with prevalence, incidence, and progression of aortic valve calcification (AVC).

Methods: We conducted a prospective study in a population-based sample of Japanese men aged 40-79 years without known cardiovascular disease and chronic kidney disease at baseline, and quantified AVC from serial computed tomographic images with the Agatston method.

Results: Of 938 participants at baseline (mean age, 63.7 ± 9.9 years), AVC prevalence was observed in 173 (18.4%). Of 596 participants without baseline AVC at follow-up (median duration, 5.1 years), AVC incidence was observed in 138 (23.2%). After adjustment for demographics, behaviors and cardiovascular risk factors, relative risks (95% confidence intervals) in the highest versus lowest categories of serum magnesium, phosphorus, and calcium were 0.62 (0.44-0.86), 1.45 (1.02-2.04), and 1.43 (0.95-2.15), respectively, for AVC prevalence and 0.62 (0.42-0.92), 1.93 (1.28-2.91), and 1.09 (0.77-1.55), respectively, for AVC incidence. Their linear trends of serum magnesium and phosphorus were also all statistically significant. Of 131 participants with baseline AVC, there was no association of any serum micronutrients with AVC progression.

Conclusions: Serum magnesium was inversely associated, while serum phosphorus was positively associated with AVC prevalence and incidence, suggesting that these serum micronutrients may be potential candidates for risk prediction or prevention of CAVD, and warranting further studies.

Keywords: Aortic valve disease; Calcification; Epidemiology; Magnesium; Phosphorus; Prospective study.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors declared they do not have anything to disclose regarding conflict of interest with respect to this manuscript.

Figures

Figure 1
Figure 1. Association of demographics, behavioral and cardiovascular risk factors, and serum micronutrients with AVC prevalence
Circle markers and horizontal lines indicate relative risks and 95% CI for AVC prevalence, respectively. Relative risks for continuous variables are expressed as per 1 standard deviation higher in values of each factor, with the following exception: pack-year smoking and C-reactive protein (per 1-log higher). All variables listed were mutually adjusted and further adjusted for computed tomography type. AVC, aortic valve calcification; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Figure 2
Figure 2. Association of demographics, behavioral and cardiovascular risk factors, and serum micronutrients with AVC incidence
Circle markers and horizontal lines indicate relative risks and 95% CI for AVC incidence, respectively. Relative risks for continuous variables are expressed as per 1 standard deviation higher in values of each factor, with the following exception: pack-year smoking and C-reactive protein (per 1-log higher). All variables listed were mutually adjusted and further adjusted for computed tomography type and follow-up duration. Abbreviations are shown in Fig. 1.
See this image and copyright information in PMC

Comment in

References

    1. Rajamannan NM, Moura L. The lipid hypothesis in calcific aortic valve disease: The role of the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36:774–776. - PubMed
    1. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O'Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM. Calcific aortic valve disease: Not simply a degenerative process: A review and agenda for research from the national heart and lung and blood institute aortic stenosis working group. Executive summary: Calcific aortic valve disease-2011 update. Circulation. 2011;124:1783–1791. - PMC - PubMed
    1. Owens DS, Budoff MJ, Katz R, Takasu J, Shavelle DM, Carr JJ, Heckbert SR, Otto CM, Probstfield JL, Kronmal RA, O'Brien KD. Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population. JACC Cardiovasc Imaging. 2012;5:619–625. - PMC - PubMed
    1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–147. - PubMed
    1. Saikrishnan N, Kumar G, Sawaya FJ, Lerakis S, Yoganathan AP. Accurate assessment of aortic stenosis: A review of diagnostic modalities and hemodynamics. Circulation. 2014;129:244–253. - PubMed

Publication types

Supplementary concepts

LinkOut - more resources